|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.42 USD | -4.41% |
|
+3.84% | +19.26% |
| Market Cap | 3.57B 3.14B 2.92B 2.68B 5.03B 344B 5.11B 34.67B 13.55B 169B 13.42B 13.13B 585B | P/E 2026 * |
-7.73x | P/E 2027 * | -8.43x |
|---|---|---|---|---|---|
| Enterprise Value | 2.95B 2.59B 2.41B 2.21B 4.16B 284B 4.22B 28.64B 11.19B 140B 11.09B 10.85B 483B | EV / Sales 2026 * |
34.7x | EV / Sales 2027 * | 35.6x |
| Free-Float |
70.85% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -4.41% | ||
| 1 week | +3.84% | ||
| Current month | -7.82% | ||
| 1 month | -8.32% | ||
| 3 months | +11.45% | ||
| 6 months | +26.42% | ||
| Current year | +19.26% |
| 1 week | 28.21 |  | 31.09 |
| 1 month | 25.68 | | 31.74 |
| Current year | 18.52 | | 31.74 |
| 1 year | 8.84 | | 31.74 |
| 3 years | 6.5 | | 31.74 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 68 | 01/05/2015 |
Terry Rosen
CEO | Chief Executive Officer | 67 | 01/05/2015 |
Robert Goeltz
DFI | Director of Finance/CFO | 53 | 01/08/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 67 | 01/12/2017 |
Kathryn Falberg
BRD | Director/Board Member | 65 | 18/09/2017 |
Yasunori Kaneko
BRD | Director/Board Member | 71 | 01/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/7/26 | Sell | Founder | -20,067 | 0.0160% | ||
| 24/6/26 | Sell | Founder | -6,431 | 0.0051% | ||
| 11/6/26 | Free | Director | 22,600 | 0.0180% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.41% | +3.84% | +177.81% | +46.19% | 3.57B | |
| +1.75% | -1.24% | -1.27% | +11.29% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +647.65% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +60.81% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.31% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +43.00% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.44% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.90% | -5.77% | +2.42% | +7.89% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -34.51% | 12.7B | |
| Average | -0.12% | +1.13% | +69.14% | +100.72% | 24.89B | |
| Weighted average by Cap. | +0.56% | +0.96% | +76.76% | +136.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 85.06M 74.71M 69.48M 63.75M 120M 8.19B 122M 825M 322M 4.03B 319M 312M 13.92B | 93.06M 81.73M 76.01M 69.75M 131M 8.96B 133M 903M 353M 4.41B 349M 342M 15.23B |
| Net income | -456M -401M -373M -342M -643M -43.95B -653M -4.43B -1.73B -21.61B -1.71B -1.68B -74.71B | -431M -378M -352M -323M -606M -41.46B -616M -4.18B -1.63B -20.38B -1.62B -1.58B -70.48B |
| Net Debt | -621M -546M -508M -466M -875M -59.83B -889M -6.03B -2.35B -29.42B -2.33B -2.28B -102B | -259M -228M -212M -194M -365M -24.98B -371M -2.52B -983M -12.28B -974M -953M -42.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | US$28.42 | -4.41% | 1,230,517 |
| 23/07/26 | US$29.73 | -0.80% | 1,217,570 |
| 22/07/26 | US$29.97 | +1.66% | 1,035,308 |
| 21/07/26 | US$29.48 | +4.65% | 1,084,357 |
| 20/07/26 | US$28.17 | +2.92% | 1,127,440 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
